Trial intelligence / Profile preview

Gabapentin and pregabalin premedication versus placebo for postoperative pain after septoplasty

IRCT20120215009014N248Phase 2Completed

Sponsor
Hamadan University of Medical Sciences
Start
Apr 2017
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, randomised trial in deviated nasal septum (DNS) comparing Gabapentin premedication, Pregabalin premedication and Placebo (3 arms). Primary endpoint: Pain measurement. Started Apr 2017; status: completed.

02

Drugs

gabapentinpregabalin
03

Conditions

deviated nasal septum (DNS)

Beyond the preview

Go deeper on IRCT20120215009014N248.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20120215009014N248.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call